AgeX Therapeutics, Inc. Common Stock (par value $0.0001 per share) At-the- Market Offering Sales AgreementSales Agreement • January 8th, 2021 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • New York
AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Chardan Capital Markets, LLC (the “Agent”), as follows:
